95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-25.55%
Negative revenue growth while AEM stands at 6.47%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-29.83%
Negative gross profit growth while AEM is at 1.90%. Joel Greenblatt would examine cost competitiveness or demand decline.
-19.91%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-19.91%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-18.31%
Negative net income growth while AEM stands at 68.18%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10.00%
Negative EPS growth while AEM is at 66.67%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.11%
Negative diluted EPS growth while AEM is at 66.67%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
4.01%
Share count expansion well above AEM's 0.08%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.11%
Reduced diluted shares while AEM is at 0.09%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-41.69%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-41.69%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
115.32%
10Y revenue/share CAGR at 50-75% of AEM's 217.79%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
59.36%
5Y revenue/share CAGR at 50-75% of AEM's 118.09%. Martin Whitman would worry about a lagging mid-term growth trajectory.
46.89%
Positive 3Y CAGR while AEM is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
580.66%
Below 50% of AEM's 1287.06%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
89.09%
Positive 3Y OCF/share CAGR while AEM is negative. John Neff might see a big short-term edge in operational efficiency.
No Data
No Data available this quarter, please select a different quarter.
506.67%
5Y net income/share CAGR above 1.5x AEM's 169.71%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
114.08%
Below 50% of AEM's 311.08%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
934.37%
10Y equity/share CAGR above 1.5x AEM's 407.59%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
1372.10%
5Y equity/share CAGR above 1.5x AEM's 222.01%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
249.39%
3Y equity/share CAGR above 1.5x AEM's 155.00%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-83.67%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-8.63%
Negative asset growth while AEM invests at 8.23%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.58%
50-75% of AEM's 1.15%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-27.61%
We’re deleveraging while AEM stands at 300.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-40.67%
We cut SG&A while AEM invests at 10.96%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.